On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
出版年份 2020 全文链接
标题
On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-02-01
DOI
10.3389/fphar.2019.01664
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Drug repurposing for antimicrobial discovery
- (2019) Maya A. Farha et al. Nature Microbiology
- Drug Repurposing for the Treatment of Bacterial and Fungal Infections
- (2019) Andrea Miró-Canturri et al. Frontiers in Microbiology
- Can cardiovascular drugs support cancer treatment? The rationale for drug repurposing
- (2019) Katarzyna Regulska et al. DRUG DISCOVERY TODAY
- The European Medicines Agency’s goals for regulatory science to 2025
- (2019) Philip A. Hines et al. NATURE REVIEWS DRUG DISCOVERY
- Drug Repositioning in Oncology
- (2019) Marissa B. Serafin et al. AMERICAN JOURNAL OF THERAPEUTICS
- Finding hidden treasures in old drugs: the challenges and importance of licensing generics
- (2018) Melek Simsek et al. DRUG DISCOVERY TODAY
- Overcoming the legal and regulatory barriers to drug repurposing
- (2018) Alasdair Breckenridge et al. NATURE REVIEWS DRUG DISCOVERY
- The promise and challenges of drug repurposing in psychiatry
- (2018) Maurizio Fava World Psychiatry
- Dutch hospital makes own drug for rare condition after manufacturer hikes price to €170 000
- (2018) Tony Sheldon BMJ-British Medical Journal
- New uses for old drugs
- (2018) Pan Pantziarka et al. BMJ-British Medical Journal
- Dutch hospital makes own drug for rare condition after manufacturer hikes price to €170 000
- (2018) Tony Sheldon BMJ-British Medical Journal
- New uses for old drugs
- (2018) Pan Pantziarka et al. BMJ-British Medical Journal
- Outdated Prescription Drug Labeling
- (2018) Michael B. Shea et al. Therapeutic Innovation & Regulatory Science
- Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead
- (2018) Rashmi R. Shah et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- CNS repurposing - Potential new uses for old drugs: Examples of screens for Alzheimer's disease, Parkinson's disease and spasticity
- (2018) Chris G. Parsons NEUROPHARMACOLOGY
- The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions
- (2018) Prasanthi Polamreddy et al. DRUG DISCOVERY TODAY
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Encouraging New Uses for Old Drugs
- (2017) Rachel E. Sachs et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Scientific advice — is drug repurposing missing a trick?
- (2017) Pan Pantziarka Nature Reviews Clinical Oncology
- Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics
- (2017) J. Javier Hernandez et al. Frontiers in Oncology
- Extensions of indication throughout the drug product lifecycle: a quantitative analysis
- (2016) Joris Langedijk et al. DRUG DISCOVERY TODAY
- Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds
- (2016) Roberto Würth et al. DRUG DISCOVERY TODAY
- Reincarnated medicines: using out-dated drugs for novel indications
- (2016) Roberto Ferrari et al. EUROPEAN HEART JOURNAL
- Time to Reassess the Cancer Compendia for Off-label Drug Coverage in Oncology
- (2016) Angela K. Green et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Can you teach old drugs new tricks?
- (2016) Nicola Nosengo NATURE
- Repurposing Drugs to Target the Diabetes Epidemic
- (2016) Nigel Turner et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Association of Off-label Drug Use and Adverse Drug Events in an Adult Population
- (2016) Tewodros Eguale et al. JAMA Internal Medicine
- Drug repositioning and repurposing: terminology and definitions in literature
- (2015) Joris Langedijk et al. DRUG DISCOVERY TODAY
- The Roles Of Academia, Rare Diseases, And Repurposing In The Development Of The Most Transformative Drugs
- (2015) Aaron S. Kesselheim et al. HEALTH AFFAIRS
- Drug repurposing in oncology—patient and health systems opportunities
- (2015) Francesco Bertolini et al. Nature Reviews Clinical Oncology
- A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma
- (2015) Christine Léauté-Labrèze et al. NEW ENGLAND JOURNAL OF MEDICINE
- The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?
- (2015) Gavin Giovannoni et al. Multiple Sclerosis and Related Disorders
- Ethical and legal framework and regulation for off-label use: European perspective
- (2014) Christian Lenk et al. Therapeutics and Clinical Risk Management
- Overcoming obstacles to repurposing for neurodegenerative disease
- (2014) Diana W. Shineman et al. Annals of Clinical and Translational Neurology
- Systematic Review: Reliability of Compendia Methods for Off-Label Oncology Indications
- (2013) Amy P. Abernethy ANNALS OF INTERNAL MEDICINE
- Challenges and opportunities of drug repositioning
- (2013) Natalia Novac TRENDS IN PHARMACOLOGICAL SCIENCES
- Repurposing as a strategy for orphan drug development, evidence from European approvals
- (2013) Peter Norman Expert Opinion on Orphan Drugs
- Drug Repurposing: Far Beyond New Targets for Old Drugs
- (2012) T. I. Oprea et al. AAPS Journal
- Repurposing Approved and Abandoned Drugs for the Treatment and Prevention of Cancer through Public-Private Partnership
- (2012) S. J. Weir et al. CANCER RESEARCH
- Drug repurposing in pediatrics and pediatric hematology oncology
- (2012) Julie Blatt et al. DRUG DISCOVERY TODAY
- Hybrid or Mixed Marketing Authorization Application in the European Union
- (2012) Andreas M. Vogel DRUG INFORMATION JOURNAL
- Do we need authorized orphan drugs when compounded medications are available?
- (2012) M. Dooms et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- PHP15 What Price do we Pay for Repurposing Medicines for Rare Diseases?
- (2012) S. Simoens et al. VALUE IN HEALTH
- Off-label use of approved drugs
- (2009) Vincent T. DeVita Nature Reviews Clinical Oncology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now